Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Jun 5, 2026, 4:00 PM EDT
6.89
-0.11 (-1.57%)
After-hours: Jun 5, 2026, 5:54 PM EDT
LIXT Market Cap
LIXT has a market cap or net worth of $81.33 million as of June 5, 2026. Its market cap has increased by 2,159.04% in one year.
Market Cap
81.33M
Enterprise Value
79.13M
1-Year Change
2,159.04%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since November 25, 2020, LIXT's market cap has increased from $47.40M to $81.33M, an increase of 71.57%. That is a compound annual growth rate of 10.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 86.70M | 287.05% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 87.26M |
| Aardvark Therapeutics | 86.61M |
| Rallybio | 85.69M |
| Adicet Bio | 85.16M |
| Annovis Bio | 84.66M |
| NeurAxis | 83.64M |
| OS Therapies | 82.40M |
| LeonaBio | 80.88M |